Cleveland Clinic Myeloma Program Hematology & Medical Oncology /R35

Cleveland, Ohio 44195

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma — Completed